Status:
RECRUITING
Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction
Lead Sponsor:
Rabin Medical Center
Collaborating Sponsors:
Sheba Medical Center
Conditions:
Hydronephrosis; Obstruction, Ureter
Renal Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. This study aim to compare tandem 6 Fr Percuflex™ stents and single large-caliber 8Fr silicone st...
Detailed Description
Malignant ureteral obstruction (MUO) is an extrinsic ureteral obstruction caused by malignant diseases. MUO may induce renal failure, which would be a barrier to several therapies including chemothera...
Eligibility Criteria
Inclusion
- patient with malignant ureteral obstruction
Exclusion
- ureteral obstruction of other causes
- Language comprehension or other limitation in giving informed consent
Key Trial Info
Start Date :
December 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT05992363
Start Date
December 20 2023
End Date
December 1 2027
Last Update
July 24 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rabin Medical Center
Petah Tikva, Israel, 49414
2
Sheba medical center
Ramat Gan, Israel